SMA Capital »

Protagonist Therapeutics shares owned by SMA Capital

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by SMA Capital from 13F filings

Historical chart of SMA Capital investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by SMA Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by SMA Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $10k 84 122.58

More positions owned by SMA Capital

Ametek (AME)
IDEX Corporation (IEX)
Parker-Hannifin Corporation (PH)
Johnson Controls Internation SHS (JCI)
CRH Ord (CRH)
Packaging Corporation of America (PKG)
J.B. Hunt Transport Services (JBHT)
Itt (ITT)
Teledyne Technologies Incorporated (TDY)
CSX Corporation (CSX)
Corteva (CTVA)
Ingersoll Rand (IR)
Amphenol Corp-cl A Cl A (APH)
Union Pacific Corporation (UNP)
Nordson Corporation (NDSN)

View all positions for SMA Capital

Top funds holding Protagonist Therapeutics

BlackRock
Farallon Capital Management
UBS Group
Rtw Investments
Vanguard Portfolio Management
Wellington Management Company
State Street Corporation
Henderson Group
Vanguard Capital Management
Johnson & Johnson
Invesco
Jupiter Topco
Geode Capital Management
T. Rowe Price Associates
Woodline Partners

View all funds holding Protagonist Therapeutics